TG Therapeutics | TGTX - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 58.94B 4.03B 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Amgen USD 51.89B 1.88B 2026-03
Ardelyx USD 203.52M 683K 2026-03
Arrowhead Research USD 1.23B 687.3M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Biogen USD 6.29B 1.7M 2026-03
Curis USD 29.43M 10.69M 2024-06
Gilead Sciences USD 20.86B 1.27B 2026-03
J&J USD 37.53B 1.91B 2026-03
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Novartis USD 37.45B 7.86B 2026-03
Novavax USD 246.3M 200K 2025-12
PTC Therapeutics USD 286.94M 1.74B 2026-03
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
TG Therapeutics USD 745.14M 499.5M 2026-03
Verastem USD 81.33M 31.01M 2025-12
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12